In Vitro and In Vivo Investigations of Chromone Derivatives as Potential Multitarget-Directed Ligands: Cognitive Amelioration Utilizing a Scopolamine-Induced Zebrafish Model-Reference-Cited by-同舟云学术

In Vitro and In Vivo Investigations of Chromone Derivatives as Potential Multitarget-Directed Ligands: Cognitive Amelioration Utilizing a Scopolamine-Induced Zebrafish Model

Published:2024-05-25 Issue:14 Volume:15 Page:2565-2585
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Kumar Naveen¹,Jangid Kailash¹²^ORCID,Kumar Vishal³,Yadav Ravi Prakash⁴,Mishra Jayapriya⁵,Upadhayay Shubham³,Kumar Vinay¹,Devi Bharti¹,Kumar Vijay¹^ORCID,Dwivedi Ashish Ranjan²⁶,Kumar Puneet³,Baranwal Somesh⁴,Bhatti Jasvinder Singh⁵,Kumar Vinod¹^ORCID

Affiliation:

1. Laboratory of Organic and Medicinal Chemistry, Department of Chemistry, Central University of Punjab, Bathinda, Punjab 151401, India

2. Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, Punjab 151401, India

3. Department of Pharmacology, Central University of Punjab, Bathinda, Punjab 151401, India

4. Gastrointestinal Disease Lab, Department of Microbiology, Central University of Punjab, Bathinda, Punjab 151401, India

5. Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, Central University of Punjab, Bathinda, Punjab 151401, India

6. Gitam School of Pharmacy, Hyderabad, Telangana 502329, India

Funder

Indian Council of Medical Research

Council of Scientific and Industrial Research, India

University Grants Commission

Science and Engineering Research Board

Department of Science and Technology, Ministry of Science and Technology, India

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.4c00007

Reference52 articles.

1. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

2. History and progress of hypotheses and clinical trials for Alzheimer’s disease

3. Diverse proteins aggregate in mild cognitive impairment and Alzheimer’s disease brain

4. Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases

5. Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenylstyrylpyrimidine derivatives as potential multipotent therapeutics for Alzheimer's disease;RSC Medicinal Chemistry;2024